✦ LIBER ✦

Long-Term Results of a Phase III Randomized Trial of Postoperative Radiotherapy With or Without Carboplatin in Patients With High-Risk Head and Neck Cancer

✍ Scribed by Athanassios Argiris; Michalis V. Karamouzis; Jonas T. Johnson; Dwight E. Heron; Eugene Myers; David Eibling; Elmer Cano; Susan Urba; Jack Gluckman; Jennifer R. Grandis; Yun Wang; Sanjiv S. Agarwala

Book ID: 110089121
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 141 KB
Volume: 118
Category: Article
ISSN: 0023-852X
DOI: 10.1097/mlg.0b013e31815b48f4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Postoperative accelerated radiotherapy i

Postoperative accelerated radiotherapy in high-risk squamous cell carcinoma of the head and neck: Long-term results of a prospective trial

✍ Andy Trotti; Douglas Klotch; James Endicott; Marion Ridley; Alan Cantor 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 42 KB 👁 2 views

## Background: For patients treated with combination resection and postoperative radiotherapy, the interval between surgery and completion of radiotherapy represents an opportunity for tumor repopulation and treatment failure. a prospective trial to test the feasibility and efficacy of accelerated

Patterns of failure and long-term result

Patterns of failure and long-term results in high-risk resected gastric cancer treated with postoperative radiotherapy with or without intraoperative electron boost

✍ Martínez-Monge, Rafael; Calvo, Felipe A.; Azinovic, Ignacio; Aristu, Jose Javier 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB 👁 2 views

## Background: To evaluate the possible role of adjuvant radiotherapy in the management of high-risk resected gastric carcinoma. ## Methods: From 1982 to 1993, 62 patients surgically resected of a primary gastric cancer with adverse pathological features (serosal and/or regional lymph node involv

Phase III randomized double blind placeb

Phase III randomized double blind placebo controlled trial of carboplatin and radiation therapy ± amifostine in patients with head and neck cancer

✍ J. Buentzel; A. Monnier; J. Ammon; G. Schmitt; N. Willich; L. Hammershaimb; G. A 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 20 KB

Accelerated versus Conventional Radiothe

Accelerated versus Conventional Radiotherapy with Concomitant Chemotherapy in Locally Advanced Head and Neck Carcinomas: Results of a Phase III Randomized Trial

✍ J. Bourhis; C. Sire; M. Lapeyre; V. Grégoire; P. Maingon; G. Calais; L. Martin; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Randomized phase 2 study of concomitant

Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer

✍ Robert Haddad; Stephen Sonis; Marshall Posner; Lori Wirth; Rosemary Costello; Pa 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 272 KB 👁 1 views

## Abstract ## BACKGROUND: A randomized phase 2 study was performed to investigate the efficacy/toxicity of combining concomitant boost radiation and weekly carboplatin/paclitaxel with or without amifostine in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). ##

Mature results from a randomized Phase I

Mature results from a randomized Phase II trial of cisplatin plus 5-fluorouracil and radiotherapy with or without tirapazamine in patients with resectable Stage IV head and neck squamous cell carcinomas

✍ Quynh-Thu Le; Al Taira; Sherie Budenz; Mary Jo Dorie; Don R. Goffinet; Willard E 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB 👁 1 views